Clinical trial · Observational
Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): After PI and vendor discussions, the decision was made not to proceed with the contract. The vendor's focus on large commercial efforts limits feasibility to support St. Jude clinical trial work.
Summary
Brief summary (as posted)
This feasibility study evaluates a 12-week, multi-component remote assessment program for adult survivors of childhood cancer. The study aims to determine the participation and adherence rates to remote monitoring of cardiometabolic health using wearable devices, surveys, and laboratory testing facilitated by a third-party vendor. Primary Objective - To establish the feasibility of a multi-component remote assessment program for adult survivors. * The primary outcome for feasibility will be the participation rate (# eligible survivors approached who enroll) and completion rate (# of eligible survivors who enroll and remain on study through completion). * An additional outcome for feasibility will be adherence to the multicomponent remote assessment among participants. Secondary Objective * To estimate the proportion of participants who complete each individual study component (adherence to each individual component monitoring).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Remote Monitoring Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Remote Monitoring Group
- description
- Participants will undergo a 12-week remote monitoring program using wearable devices and complete surveys and a one-time lab draw. A subset will participate in interviews post-intervention.
- interventionNames
- Behavioral: Remote Monitoring Program
Primary outcomes (4)
- measure
- Participation rate
- timeFrame
- Assessed at contact for enrollment of each participant (baseline/screening).
- description
- The proportion of eligible survivors approached who enroll in the intervention
- measure
- On-boarding rate
- timeFrame
- Baseline at study entry through week 12
- description
- The proportion of consented participants who successful onboard with the vendor and contribute any study data beyond baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participant is ≥18 years of age * Participant is enrolled in the St. Jude Life (SJLIFE) cohort * Participant is able and willing to provide informed consent * Participant has signed a separate consent for the St. Jude banking protocol (TBANK) * Participant received anthracycline (≥100 mg/m²), chest or abdominal radiation as part of childhood cancer treatment * Participant owns a SmartPhone compatible with the vendor platform, Apple HealthKit, and Dexcom (a wearable device that continuously tracks glucose levels) * Participant verbalizes understanding directions for completing remote study activities with the third-party partner * Participant is fluent in English Exclusion Criteria: * Participant uses a continuous glucose monitor for diabetes management or has diabetes requiring insulin or more than 1 agent for treatment at baseline * Participant is currently enrolled on an intervention or active longitudinal monitoring ancillary study
References
Publications (0)
Data not yet available